MEDICAL DEVICE WITH EXTENDED WEAR ADHESIVE PATCH

    公开(公告)号:US20190336078A1

    公开(公告)日:2019-11-07

    申请号:US16400878

    申请日:2019-05-01

    摘要: An adhesive patch for a medical device having a hub, such as an infusion device, is provided. The adhesive patch includes a first backing layer to be coupled to the medical device. The first backing layer is composed of a first material. The adhesive patch includes a first adhesive layer coupled to the first backing layer and a second backing layer coupled to the first adhesive layer. The second backing layer is composed of a second material, and the second material is different than the first material. The adhesive patch includes a biocompatible second adhesive layer coupled to the second backing layer, and the second adhesive layer is to be coupled to an anatomy.

    FLUID CONDUIT ASSEMBLY WITH GAS TRAPPING FILTER IN THE FLUID FLOW PATH
    7.
    发明申请
    FLUID CONDUIT ASSEMBLY WITH GAS TRAPPING FILTER IN THE FLUID FLOW PATH 审中-公开
    在流体流路中使用气体捕集过滤器的流体管路组件

    公开(公告)号:US20160095987A1

    公开(公告)日:2016-04-07

    申请号:US14508934

    申请日:2014-10-07

    摘要: A fluid delivery system and a fluid conduit assembly suitable for use with the system are disclosed herein. The system includes a fluid infusion pump and a fluid conduit assembly coupled to the pump to deliver medication fluid to a user. The fluid conduit assembly includes a structure defining a flow path for the medication fluid, and a gas trapping filter coupled to the structure and positioned in the flow path. The gas trapping filter functions to filter particulates from the medication fluid and retain gas bubbles from the medication fluid.

    摘要翻译: 本文公开了适用于该系统的流体输送系统和流体导管组件。 该系统包括流体输注泵和连接到泵的流体导管组件,以向使用者输送药物流体。 流体导管组件包括限定用于药物流体的流动路径的结构以及耦合到结构并且定位在流动路径中的气体捕获过滤器。 气体捕集过滤器用于过滤来自药物流体的颗粒并保留来自药物流体的气泡。

    Medication infusion components and systems

    公开(公告)号:US11197949B2

    公开(公告)日:2021-12-14

    申请号:US15874757

    申请日:2018-01-18

    摘要: This invention pertains to systems and components useful for infusing medications such as insulin. Typically, the components are used to deliver insulin to a diabetic patient at a site of infusion over a period of time greater than 4 days. The system components typically comprise a cannula adapted for subcutaneous insertion into a diabetic patient. The system further comprises a fluid conduit adapted to deliver the insulin solution from a medication reservoir to the site of infusion and a depot in operable contact with the fluid conduit. The depot comprises selected materials including a site-loss mitigating agent (such as heparin) which inhibits inflammation at the site of infusion, and encapsulation of the cannula at the site of infusion. The site-loss mitigating agent is not premixed with the insulin, and instead is adapted to contact the insulin solution in the depot as the insulin solution flows from the medication reservoir to the site of infusion.